Planning & Drug Selection Working Group

Chair: Scott Gavura (Director, Provincial Drug Reimbursement Programs, Cancer Care Ontario)

The Planning and Drug Selection Working Group was established to develop criteria to identify potential drug indication candidates and select high-priority study questions for real world evaluation. The focus of the Planning and Drug Selection Working Group is on identifying uncertainties at the time of drug funding that may be resolvable through the generation of RWE, along with considerations that should be factored into priority-setting among a basket of drug candidates. In addition, this Group will provide recommendations on potential infrastructure for conducting RWE studies.